Loading...
XSTO
ARJO B
Market cap918mUSD
Dec 04, Last price  
31.78SEK
1D
0.70%
1Q
-6.14%
IPO
30.51%
Name

Arjo AB (publ)

Chart & Performance

D1W1MN
XSTO:ARJO B chart
P/E
17.38
P/S
0.77
EPS
1.83
Div Yield, %
2.83%
Shrs. gr., 5y
Rev. gr., 5y
4.82%
Revenues
11.29b
+2.84%
7,568,000,0008,115,000,0007,808,000,0007,688,000,0008,217,000,0008,925,000,0009,078,000,0009,070,000,0009,979,000,00010,980,000,00011,292,000,000
Net income
498m
+3.75%
619,000,000307,000,000490,000,000118,000,000296,000,000403,000,000526,000,000742,000,000449,000,000480,000,000498,000,000
CFO
1.52b
-26.44%
959,000,000811,000,000919,000,000572,000,000991,000,0001,252,000,0002,267,000,0001,734,000,000915,000,0002,061,000,0001,516,000,000
Dividend
Apr 30, 20250.95 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
IPO date
Dec 12, 2017
Employees
6,800
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT